Cargando…
Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381925/ https://www.ncbi.nlm.nih.gov/pubmed/32773341 http://dx.doi.org/10.1016/j.schres.2020.07.015 |
| _version_ | 1783563150127267840 |
|---|---|
| author | Nobile, B. Durand, M. Courtet, P. Van de Perre, P. Nagot, N. Molès, J.P. Olié, E. |
| author_facet | Nobile, B. Durand, M. Courtet, P. Van de Perre, P. Nagot, N. Molès, J.P. Olié, E. |
| author_sort | Nobile, B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7381925 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73819252020-07-28 Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? Nobile, B. Durand, M. Courtet, P. Van de Perre, P. Nagot, N. Molès, J.P. Olié, E. Schizophr Res Letter to the Editor Elsevier B.V. 2020-09 2020-07-25 /pmc/articles/PMC7381925/ /pubmed/32773341 http://dx.doi.org/10.1016/j.schres.2020.07.015 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Nobile, B. Durand, M. Courtet, P. Van de Perre, P. Nagot, N. Molès, J.P. Olié, E. Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
| title | Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
| title_full | Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
| title_fullStr | Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
| title_full_unstemmed | Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
| title_short | Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2? |
| title_sort | could the antipsychotic chlorpromazine be a potential treatment for sars-cov-2? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381925/ https://www.ncbi.nlm.nih.gov/pubmed/32773341 http://dx.doi.org/10.1016/j.schres.2020.07.015 |
| work_keys_str_mv | AT nobileb couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 AT durandm couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 AT courtetp couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 AT vandeperrep couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 AT nagotn couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 AT molesjp couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 AT oliee couldtheantipsychoticchlorpromazinebeapotentialtreatmentforsarscov2 |